Conversely, diminished AhR signaling in acute and chronic myeloid leukemia (AML/CML) has been shown to drive leukemic stem cell maintenance and disease progression [58,59]. Here, AHR is linked to chronic myelogenous leukemia, BCR-ABL1 positive.